Renovorx, Inc. balance sheet
At the end of fiscal 2025, Renovorx, Inc. had total assets of $8.1m, total liabilities of $2.7m and shareholders' equity of $5.4m. It held $7.0m in cash against $0 of debt.
Balance sheet
| Fiscal year | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|
| Cash and equivalents | 7 | 7 | 9 |
| Receivables | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 |
| Total current assets | 8 | 8 | 11 |
| Total assets | 8 | 8 | 11 |
| Accounts payable | 1 | 1 | 1 |
| Total current liabilities | 2 | 2 | 2 |
| Total debt | 0 | 0 | 0 |
| Total liabilities | 4 | 3 | 2 |
| Shareholders' equity | 4 | 5 | 9 |
| Shares outstanding | 24m | 37m | 45m |
| Quarter | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory | — | — | 0 | 0 | 0 | 0 |
| Total current assets | 16 | 13 | 11 | 8 | 14 | 11 |
| Total assets | 16 | 14 | 11 | 8 | 14 | 11 |
| Accounts payable | 1 | 1 | 1 | 1 | 1 | 1 |
| Total current liabilities | 2 | 2 | 2 | 2 | 2 | 2 |
| Total liabilities | 3 | 3 | 3 | 3 | 3 | 2 |
| Shareholders' equity | 13 | 11 | 8 | 5 | 11 | 9 |
| Shares outstanding | 37m | 37m | 37m | 37m | 45m | 45m |
Compare with peers
- Seastar Medical Holding Corp balance sheet
- Femasys Inc balance sheet
- Insight Molecular Diagnostics Inc. balance sheet
- Volitionrx LTD balance sheet
- Pulse Biosciences, Inc. balance sheet
Head to head: ICU vs RNXTFEMY vs RNXTIMDX vs RNXT
More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies